Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
IntroductionAlzheimer's disease (AD) and Parkinson's disease (PD) are two of the most prevalent neurodegenerative disorders, necessitating accurate diagnostic approaches for early detection and effective management.MethodsThis study introduces two deep learning architectures, the Residual-based Attention Convolutional Neural Network (RbACNN) and the Inverted Residual-based Attention Convolutional Neural Network (IRbACNN), designed to enhance medical image classification for AD and PD diagnosis. By integrating self-attention mechanisms, these models improve feature extraction, enhance interpretability, and address the limitations of traditional deep learning methods. Additionally, explainable AI (XAI) techniques are incorporated to provide model transparency and improve clinical trust in automated diagnoses. Preprocessing steps such as histogram equalization and batch creation are applied to optimize image quality and balance the dataset.ResultsThe proposed models achieved an outstanding classification accuracy of 99.92%.DiscussionThe results demonstrate that these architectures, in combination with XAI, facilitate early and precise diagnosis, thereby contributing to reducing the global burden of neurodegenerative diseases.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.